Genetic Predisposition Between COVID-19 and Four Mental Illnesses: A Bidirectional, Two-Sample Mendelian Randomization Study
Open Access
- 20 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 12, 746276
Abstract
Background: The outbreak of 2019 coronavirus disease (COVID-19) has become a global pandemic. Although it has long been suspected that COVID-19 could contribute to the development of mental illness, and individuals with a pre-existing mental illness may have a higher risk of and poorer outcomes from COVID-19 infection, no evidence has established a causal association between them thus far.Methods: To investigate associations in support of a causal association between the severity of COVID-19 and mental illnesses, we leveraged large-scale genetic summary data from genome-wide association study (GWAS) summary datasets, including attention-deficit/hyperactivity disorder (ADHD) (n = 55,374), schizophrenia (n = 77,096), bipolar disorder (n = 51,710), and depression (n = 173,005), based on a previous observational study. The random-effects inverse-variance weighted method was conducted for the main analyses, with a complementary analysis of the weighted median and MR-Egger approaches and multiple sensitivity analyses assessing horizontal pleiotropy and removing outliers in two different COVID-19 databases.Results: The Mendelian randomization (MR) analysis indicated that ADHD [odds ratio (OR) = 1.297; 95% confidence interval (CI), 1.029–1.634; p = 0.028] increased the risk of hospitalization due to COVID-19. A similar association was obtained in MR sensitivity analyses of the weighted median. In addition, genetically predicted COVID-19 was significantly associated with schizophrenia (OR = 1.043; 95% CI, 1.005–1.082; p = 0.027).Conclusions: Although many studies have reported a causal relationship between COVID-19 and mental illness, our study shows that this increased risk is modest. However, considering the characteristics of ADHD that might further increase the individuals' vulnerability to being infected by COVID-19, the ongoing massive worldwide exposure to COVID-19, and the high burden of schizophrenia, we believe that it is necessary to offer preventative measures to these populations and to provide more evidence in understanding the neurological impact of COVID-19.Keywords
Funding Information
- National Science Foundation of China (81571340, 81873802)
This publication has 40 references indexed in Scilit:
- Modal-based estimation via heterogeneity-penalized weighting: model averaging for consistent and efficient estimation in Mendelian randomization when a plurality of candidate instruments are validInternational Journal of Epidemiology, 2018
- Mendelian RandomizationJAMA, 2017
- Interpreting findings from Mendelian randomization using the MR-Egger methodEuropean Journal of Epidemiology, 2017
- Global economic burden of schizophrenia: a systematic reviewNeuropsychiatric Disease and Treatment, 2016
- Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: a nationwide population-based cohort study in DenmarkThe Lancet HIV, 2015
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionInternational Journal of Epidemiology, 2015
- Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorderJournal of Psychiatric Research, 2013
- Stress and Psychological Distress among SARS Survivors 1 Year after the OutbreakThe Canadian Journal of Psychiatry, 2007
- A Systematic Review of the Prevalence of SchizophreniaPLOS Medicine, 2005
- ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*International Journal of Epidemiology, 2003